The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to investigate the effect of hospital case volume on clinical outcomes in patients with nasopharyngeal carcinoma (NPC). Materials and Methods Data on 1,073 patients with cT1-4N0-3M0 NPC were collected from a multi-institutional retrospective database (KROG 11-06). All patients received definitive radiotherapy (RT) either with three-dimensional-conformal RT (3D-CRT) (n=576) or intensity-modulated RT (IMRT) (n=497). The patients were divided into two groups treated at high volume institution (HVI) (n=750) and low volume institution (LVI) (n=323), defined as patient volume 10 (median, 13; range, 10 to 18) and < 10 patients per year (median, 3; range, 2 to 6), respectively. Endpoints were overall survival (OS) and loco-regional progression-free survival (LRPFS). Results At a median follow-up of 56.7 months, the outcomes were significantly better in those treated at HVI than at LVI. For the 614 patients of propensity score-matched cohort, 5-year OS and LRPFS were consistently higher in the HVI group than in the LVI group (OS: 78.4% vs. 62.7%, p < 0.001; LRPFS: 86.2% vs. 65.8%, p < 0.001, respectively). According to RT modality, significant difference in 5-year OS was observed in patients receiving 3D-CRT (78.7% for HVI vs. 58.9% for LVI, p < 0.001) and not in those receiving IMRT (77.3% for HVI vs. 75.5% for LVI, p=0.170). Conclusion A significant relationship was observed between HVI and LVI for the clinical outcomes of patients with NPC. However, the difference in outcome becomes insignificant in the IMRT era, probably due to the standardization of practice by education.
Abstract
Purpose The purpose of this study was to investigate the effect of hospital case volume on clinical outcomes in patients with nasopharyngeal carcinoma (NPC). Materials and Methods Data on 1,073 patients with cT1-4N0-3M0 NPC were collected from a multi-institutional retrospective database (KROG 11-06). All patients received definitive radiotherapy (RT) either with three-dimensional-conformal RT (3D-CRT) (n=576) or intensity-modulated RT (IMRT) (n=497). The patients were divided into two groups treated at high volume institution (HVI) (n=750) and low volume institution (LVI) (n=323), defined as patient volume 10 (median, 13; range, 10 to 18) and < 10 patients per year (median, 3; range, 2 to 6), respectively. Endpoints were overall survival (OS) and loco-regional progression-free survival (LRPFS). Results At a median follow-up of 56.7 months, the outcomes were significantly better in those treated at HVI than at LVI. For the 614 patients of propensity score-matched cohort, 5-year OS and LRPFS were consistently higher in the HVI group than in the LVI group (OS: 78.4% vs. 62.7%, p < 0.001; LRPFS: 86.2% vs. 65.8%, p < 0.001, respectively). According to RT modality, significant difference in 5-year OS was observed in patients receiving 3D-CRT (78.7% for HVI vs. 58.9% for LVI, p < 0.001) and not in those receiving IMRT (77.3% for HVI vs. 75.5% for LVI, p=0.170). Conclusion A significant relationship was observed between HVI and LVI for the clinical outcomes of patients with NPC. However, the difference in outcome becomes insignificant in the IMRT era, probably due to the standardization of practice by education.
참고문헌 (17)
- Birkmeyer JD, "Hospital volume and surgical mortality in the United States", N Engl J Med, 346, pp.1128~1137 (2002)
- Gruen RL, "The effect of provider case volume on cancer mortality : systematic review and meta-analysis", CA Cancer J Clin, 59, pp.192~211 (2009)
- Schrag D, "Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection", Ann Surg, 236, pp.583~592 (2002)
- Das IJ, "Intensity-modulated radiation therapy dose prescription, recording, and delivery : patterns of variability among institutions and treatment planning systems", J Natl Cancer Inst, 100, pp.300~307 (2008)
- Hong TS, "Heterogeneity in head and neck IMRT target design and clinical practice", Radiother Oncol, 103, pp.92~98 (2012)
- Nelms BE, "Variation in external beam treatment plan quality : an inter-institutional study of planners and planning systems", Pract Radiat Oncol, 2, pp.296~305 (2012)
- Moon SH, "IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)", Strahlenther Onkol, 192, pp.377~385 (2016)
- 성수윤, "Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea", Radiation oncology journal, 33(3), pp.188~197 (2015), 대한방사선종양학회
- Chen YW, "Association between treatment at a high-volume facility and improved survival for radiation-treated men with high-risk prostate cancer", Int J Radiat Oncol Biol Phys, 94, pp.683~690 (2016)
- Koshy M, "Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer", Radiother Oncol, 114, pp.148~154 (2015)
- Wang EH, "Patients selected for definitive concurrent chemoradiation at high-volume facilities achieve improved survival in stage III non-small-cell lung cancer", J Thorac Oncol, 10, pp.937~943 (2015)
- Lee CC, "Survival rate in nasopharyngeal carcinoma improved by high caseload volume : a nationwide population-based study in Taiwan", Radiat Oncol, 6, pp.92~ (2011)
- Wuthrick EJ, "Institutional clinical trial accrual volume and survival of patients with head and neck cancer", J Clin Oncol, 33, pp.156~164 (2015)
- Boero IJ, "Importance of radiation oncologist experience among patients with head-and-neck cancer treated with intensity-modulated radiation therapy", J Clin Oncol, 34, pp.684~690 (2016)
- Lee N, "Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma : an update of the UCSF experience", Int J Radiat Oncol Biol Phys, 53, pp.12~22 (2002)
- Al-Sarraf M, "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer : phase III randomized Intergroup study 0099", J Clin Oncol, 16, pp.1310~1317 (1998)
- Langendijk JA, "The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature", J Clin Oncol, 22, pp.4604~4612 (2004)